Majumder, Mousumi <br/><br/>
Prostaglandin E2 receptor EP4 as the common target on cancer cells and macrophages to abolish angiogenesis, lymphangiogenesis, metastasis, and stem-like cell functions.  [electronic resource] 

 -  Cancer science  Sep 2014 
 - 1142-51 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1349-7006 
<br/><br/><label>Standard No.: </label>10.1111/cas.12475  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--blood supply<br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis<br/>Benzamides--pharmacology<br/>Celecoxib<br/>Cell Line, Tumor<br/>Cell Proliferation<br/>Cyclooxygenase 2--metabolism<br/>Drug Screening Assays, Antitumor<br/>Female<br/>Lung Neoplasms--blood supply<br/>Lymphangiogenesis<br/>Lymphatic Metastasis<br/>Macrophages--metabolism<br/>Mammary Neoplasms, Experimental--blood supply<br/>Mice<br/>Mice, Inbred C3H<br/>Molecular Targeted Therapy<br/>Neoplasm Transplantation<br/>Neoplastic Stem Cells<br/>Neovascularization, Pathologic--drug therapy<br/>Pyrazoles--pharmacology<br/>Receptors, Prostaglandin E, EP4 Subtype--antagonists & inhibitors<br/>Sulfonamides--pharmacology<br/>Tumor Burden<br/>Vascular Endothelial Growth Factor A--metabolism